PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values
TH Open · 09.07.2026 · 10 (CP)
DOI: 10.1055/a-2901-2564 ↗Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 09.07.2026. Verfasst von Sabina Ugovšek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Endothelial dysfunction is an independent predictor of cardiovascular events in patients with established atherosclerosis, while the circulating levels of endothelial progenitor cells (EPCs) reflect active endothelial function in heart failure patients. Although protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9i) lower lipid concentration and reduce cardiovascular events, their impact on endothelial function remains poorly understood.
Purpose
We aimed to examine the effect of PCSK9i on the levels of EPCs in the peripheral blood of patients with chronic coronary disease and significantly elevated lipoprotein(a) (Lp(a)) concentrations.
Methods
In this randomized, double-blind, placebo-controlled trial, we included 100 statin-treated patients at least 6 months post-myocardial infarction with elevated Lp(a) values. The patients received PCSK9i or a placebo every 2 weeks for 6 months. Biochemical and flow cytometric analyses of peripheral blood mononuclear cells were performed at baseline and after 6 months.
Results
Treatment with PCSK9i increased the levels of mature EPCs (CD34+) compared with placebo (p = 0.003). In contrast, no significant effects were observed on early EPC subtypes (CD34+CD309+, CD34+CD133+, CD133+CD309+, and CD133+; p = 0.611, p = 0.451, p = 0.739, and p = 0.161, respectively). The increase in mature EPCs (CD34+) levels did not correlate with changes in PCSK9 concentration. No associations were detected between changes in PCSK9 concentration and changes in levels of EPC subtypes predominantly expressing CD309, nor between changes in levels of any EPCs and lipoprotein concentration variations at baseline or at the end of the study.
Conclusion
In patients with chronic coronary disease, treatment with PCSK9i increases circulating levels of mature CD34+ EPCs, without affecting other EPC subtypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.
- Department of Vascular DiseasesUniversity Medical Centre LjubljanaLjubljanaLjubljanaSlovenia.
- Laboratory for Translational Medical BiochemistryInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.
- Clinical Institute for Special Laboratory Diagnostics, University Children's Hospital, University Medical Centre LjubljanaLjubljanaLjubljanaSlovenia.
- Faculty of Pharmacy, University of LjubljanaLjubljanaLjubljanaSlovenia.
- Department of Internal Medicine IIMedical University of ViennaViennaViennaAustria.
ORCID-Profile: Sabina Ugovšek, Patrick Haider
Zitieren
APA
Ugovšek, S., Rehberger Likozar, A., Levstek, T., Trebušak Podkrajšek, K., Zupan, J., Marka, F., Trimmel, T., Brekalo, M., Speidl, W. S., Hohensinner, P. J., Haider, P., & Šebeštjen, M. (2026). PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values. TH Open, 10(CP). https://doi.org/10.1055/a-2901-2564
Vancouver
Ugovšek S, Rehberger Likozar A, Levstek T, Trebušak Podkrajšek K, Zupan J, Marka F, et al. PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values. TH Open. 2026;10(CP). doi:10.1055/a-2901-2564
BibTeX
@article{Ugovek2026,
author = {Ugovšek, Sabina and Rehberger Likozar, Andreja and Levstek, Tina and Trebušak Podkrajšek, Katarina and Zupan, Janja and Marka, Frieda and Trimmel, Tamara and Brekalo, Mira and Speidl, Walter S and Hohensinner, Philipp J and Haider, Patrick and Šebeštjen, Miran},
title = {PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values},
journal = {TH Open},
year = {2026},
volume = {10},
number = {CP},
doi = {10.1055/a-2901-2564}
}
EUVIMED